Abstract:Abstract Introduction Up to 20% of ST-elevation myocardial infarction (STEMI) patients who undergo primary percutaneous coronary intervention (PCI) continue to have persistent angina, which is considered to be a significant side effect of reperfusion therapy and is associated with coronary microvascular dysfunction (CMD). Purpose To determine if there is a correlation between the technique employed in primary PCI in STEMI patients and the prevalence of CMD after reperfusion. Methods This is a prospective single-blinded observational cohort study conducted in a tertiary cardiac care center in the republic of Lithuania. The study enrolled STEMI patients with multivessel coronary artery disease who underwent primary PCI. Three months later, participants underwent staged PCI of their non-culprit vessels and evaluation for CMD. CMD was defined as an index of microcirculatory resistance (IMR) value ≥ 25 U and a coronary flow reserve (CFR) value < 2.5 U. PCI technique, such as direct stenting or conventional stenting (balloon angioplasty followed by stenting), aspiration thrombectomy, and intracoronary glycoprotein IIb/IIIa inhibitor administration, were prospectively documented. We tested for overall differences in patient characteristics and outcomes between groups using Chi-Square (or Kruskal-Wallis) tests and used the Holm-Bonferroni adjustment (or Dunn's tests) for subsequent pairwise tests. We also performed logistic regression. Results 200 patients were enrolled, with 96 (48%) and 104 (52%), respectively, undergoing direct and conventional stenting. The median age was 65.5 [58, 76] years, most patients were men (59.5%) and 46 patients (23%) met criteria for CMD. Baseline characteristics and risk factors were similar between those with and without CMD. Patients who underwent direct stenting were less likely to suffer from CMD compared to those who underwent conventional stenting (10 (10.4%) vs 36 (34.6%); p < 0.001). In the logistic multivariable analysis, direct stenting, aspiration thrombectomy, and administrations of glycoprotein IIb/IIIa had a ROC AUC of 0.765, indicating good predictive ability. In this particular model, direct stenting, aspiration thrombectomy, and the administration of an intracoronary glycoprotein IIb/IIIa inhibitor were associated with decreased odds of the presence of CMD (OR: 0.193, 95% CI: 0.087-0.430, p < 0.001), (OR: 0.243, 95% CI: 0.086-0.688, p = 0.008), and (OR: 0.200, 95% CI: 0.065-0.620, p = 0.005), respectively. Conclusion In STEMI patients undergoing primary PCI, direct stenting is associated with reduced prevalence of CMD compared with conventional stenting. Furthermore, performing aspiration thrombectomy and administering a glycoprotein IIb/IIIa inhibitor was also associated with a lower prevalence of CMD.Forest plot for the outcome of CMDROC for the model of CMD

Postprocedure Anticoagulation in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Role of ST‐Segment Resolution Alone and in Combination with TIMI Flow after Primary Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction

Association of postprocedural neutrophil count and myocardial perfusion in ST elevation myocardial infarction patients after percutaneous coronary intervention

Clinical effect of postconditioning in ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

Long-term Outcome Analysis of Patients Underwent Percutaneous Coronary Intervention with Prior Ischemic Stroke

Early routine post-thrombolysis percutaneous coronary intervention vs. primary PCI in ST-segment elevated myocardial infarction: a comparative study

Impact of Angina Prior to Acute ST-elevation Myocardial Infarction on Short-Term Outcomes after Primary Percutaneous Coronary Intervention: Results from the Shanghai Registry of Acute Coronary Syndrome (SRACE).

The role of late reperfusion in ST-segment elevation myocardial infarction: a real-world retrospective cohort study

Reevaluate the effect of ACEI/ARB therapy at discharge on patients with STEMI in the contemporary reperfusion era

Impact of Emergency Percutaneous Coronary Intervention on Outcomes of ST-segment Elevation Myocardial Infarction Patients Complicated by Out-of-hospital Cardiac Arrest.

Fondaparinux Sodium for Anticoagulant Therapy After Primary Percutaneous Coronary Intervention: A Single-Center Randomized Trial in China

Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI

Reperfusion Strategy of ST-Elevation Myocardial Infarction: A Meta-Analysis of Primary Percutaneous Coronary Intervention and Pharmaco-Invasive Therapy

Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia

Combined Intracoronary Prourokinase Thrombolysis on Myocardial Perfusion and Vascular Endothelial Function in STEMI

Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients Presenting with Increased Platelet Count

Influence of percutaneous coronary intervention timing on the prognosis of patients with acute ST segment elevation myocardial infarction

Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial

The impact of primary percutaneous coronary intervention strategies during st-elevation myocardial infarction on the prevalence of coronary microvascular dysfunction

Incidence, Predictors and Clinical Significance of Periprocedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention.

Impact of post-dilatation on post-procedural physiology, microcirculatory resistance, and target vessel failure in STEMI patients undergoing PPCI: A single-center experience